Current Roles

Employees:
129
Revenue:
$20M
About
TriSalus™ is dedicated to improving patient outcomes in pancreatic and other highly intractable solid tumors. TriSalus™ has the potential to deliver novel therapeutic agents and immuno-stimulants directly into tumors’ vasculature using a proprietary Pressure-Enabled Drug DeliveryTM (PEDD™) technology to improve the distribution and penetration of therapy in solid tumors.
TriSalus Life Sciences Address
6272 W. 91st Avenue
Westminster, CO
United States
TriSalus Life Sciences Email